Tu Van Dao
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 3
-
- Smart Grid Energy Management 7
- Co-authors
- Yasuhiro Hayashi (9 shared papers)Hideo Ishii (9 shared papers)Bruno Sangro (4 shared papers)Lorenza Rimassa (4 shared papers)George Lau (4 shared papers)В. В. Бредер (4 shared papers)Philip He (1 shared paper)Vincent C. Tam (2 shared papers)
- Journals
- Cancer Control (4 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (1 paper)International Journal of Electrical Power & Energy Systems (1 paper)
- Partner nations
- VietnamJapanUnited States
In The Last Decade
Tu Van Dao
31 papers receiving 532 citations
Tu Van Dao's Hit Papers
Peers
Comparison fields: 5 of 58
- Hepatology 206
- Oncology 238
- Cancer Research 73
- Pulmonary and Respiratory Medicine 134
- Pathology and Forensic Medicine 72
Countries citing papers authored by Tu Van Dao
This map shows the geographic impact of Tu Van Dao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tu Van Dao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tu Van Dao more than expected).
Fields of papers citing papers by Tu Van Dao
This network shows the impact of papers produced by Tu Van Dao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tu Van Dao. The network helps show where Tu Van Dao may publish in the future.
Co-authors
The 25 scholars most cited alongside Tu Van Dao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA. Hit paper breakdown → | 2022 | 259 |
| 2 | 2022 | 72 | |
| 3 | 2022 | 32 | |
| 4 | 2017 | 27 | |
| 5 | 2019 | 21 | |
| 6 | 2022 | 17 | |
| 7 | 2017 | 15 | |
| 8 | 2020 | 14 | |
| 9 | 2018 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2020 | 6 | |
| 13 | 2017 | 6 | |
| 14 | 2019 | 5 | |
| 15 | [Cancer of the gallbladder. Epidemiology, diagnosis and prognostic factors]. | 1993 | 5 |
| 16 | 2021 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2022 | 2 |
About Tu Van Dao
Tu Van Dao is a scholar working on Oncology, Electrical and Electronic Engineering, Control and Systems Engineering, Pulmonary and Respiratory Medicine and Surgery, having authored 36 papers that have together received 539 indexed citations. Recurring topics across this work include Microgrid Control and Optimization (8 papers), Smart Grid Energy Management (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Renal cell carcinoma treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Hepatology (206 citations), Oncology (238 citations), Cancer Research (73 citations), Pulmonary and Respiratory Medicine (134 citations) and Pathology and Forensic Medicine (72 citations). Tu Van Dao has collaborated with scholars based in Vietnam, Japan and United States. Frequent co-authors include Yasuhiro Hayashi, Hideo Ishii, Bruno Sangro, Lorenza Rimassa, George Lau, В. В. Бредер, Philip He, Vincent C. Tam, Wattana Sukeepaisarnjaroen and Kabir Mody. Their work appears in journals such as Cancer Control, Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology and International Journal of Electrical Power & Energy Systems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.